In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 280.2 | 299.6 | 771.8 | 996.0 | 396.3 | 431.7 | 932.6 | 852.6 | 1,257.8 | 475.6 | 965.4 | 1,095.5 | |
| Other Income | 1.9 | 2.4 | 3.0 | 10.6 | 7.2 | 4.4 | 3.6 | 5.3 | 16.5 | 2.4 | 0.6 | 5.8 | |
| Total Income | 282.1 | 301.9 | 774.8 | 1,006.5 | 403.5 | 436.0 | 936.2 | 857.9 | 1,274.2 | 477.9 | 966.0 | 1,101.3 | |
| Expenses | |||||||||||||
| + Cost of Materials Consumed | 71.4 | 279.2 | 568.1 | 442.4 | 194.8 | 487.3 | 592.2 | 341.1 | 502.9 | 431.3 | 584.3 | 580.3 | |
| + Purchases of Stock-in-Trade | 26.7 | 29.3 | 66.5 | 79.0 | 51.3 | 37.8 | 113.6 | 110.5 | 177.3 | 52.1 | 125.1 | 157.0 | |
| + Changes in Inventories | 105.7 | -114.3 | -104.5 | 212.9 | 37.7 | -255.7 | -55.0 | 157.4 | 214.9 | -166.7 | -55.5 | 54.4 | |
| + Employee Benefit Expense | 42.3 | 36.9 | 45.7 | 44.5 | 46.1 | 50.4 | 52.5 | 54.4 | 107.8 | 55.4 | 61.9 | 63.4 | |
| + Finance Costs | 5.1 | 5.0 | 1.9 | 1.5 | 1.4 | 1.3 | 1.5 | 1.6 | 4.3 | 3.8 | 2.9 | 2.0 | |
| + Depreciation & Amortisation | 15.8 | 16.5 | 15.6 | 16.6 | 18.7 | 16.8 | 17.5 | 15.6 | 31.0 | 14.6 | 12.0 | 13.1 | |
| + Other Expenses | 77.7 | 71.7 | 114.7 | 160.5 | 92.9 | 101.8 | 137.7 | 152.9 | 254.2 | 104.5 | 181.9 | 199.4 | |
| Total Expenses | 344.7 | 324.2 | 708.0 | 957.5 | 442.9 | 439.7 | 859.9 | 833.4 | 1,292.4 | 494.9 | 912.5 | 1,069.6 | |
| EBITDA | -43.6 | -3.2 | 81.4 | 56.6 | -26.6 | 10.0 | 91.7 | 36.4 | 0.7 | -0.9 | 67.7 | 40.9 | |
| EBIT | -59.4 | -19.7 | 65.8 | 40.0 | -45.3 | -6.8 | 74.2 | 20.8 | -30.3 | -15.5 | 55.7 | 27.8 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | -62.6 | -22.3 | 66.8 | 49.1 | -39.4 | -3.7 | 76.3 | 24.5 | -18.2 | -17.0 | 53.5 | 31.7 | |
| + Exceptional Items | -12.1 | -13.0 | -1.8 | 0.0 | 0.0 | 0.0 | 0.0 | -3.3 | -13.3 | -7.9 | 2.8 | 0.0 | |
| Pretax Income | -74.7 | -35.3 | 65.1 | 49.1 | -39.4 | -3.7 | 76.3 | 21.2 | -31.4 | -24.8 | 56.3 | 31.7 | |
| + Current Tax | 0.6 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 1.1 | 0.7 | 0.9 | 0.9 | |
| + Deferred Tax | -18.9 | -8.7 | 15.7 | 12.4 | -10.0 | -0.9 | 19.6 | 5.3 | -7.8 | -6.5 | 14.5 | 8.0 | |
| Tax Expense | -18.3 | -8.2 | 16.3 | 12.9 | -9.4 | -0.3 | 20.2 | 5.9 | -6.7 | -5.8 | 15.4 | 8.9 | |
| Net Income | -56.4 | -27.1 | 48.8 | 36.2 | -30.1 | -3.3 | 56.1 | 15.3 | -24.7 | -19.0 | 40.9 | 22.8 | |
| + Net Income — Continuing Ops | -56.4 | -27.1 | 48.8 | 36.2 | -30.1 | -3.3 | 56.1 | 15.3 | -24.7 | -19.0 | 40.9 | 22.8 | |
| + Other Comprehensive Income | 0.4 | -0.2 | -0.9 | 0.5 | -0.3 | 0.1 | -1.1 | -0.7 | -0.3 | 1.0 | 0.3 | -0.2 | |
| Total Comprehensive Income | -56.0 | -27.3 | 47.9 | 36.6 | -30.4 | -3.2 | 55.0 | 14.6 | -25.0 | -18.0 | 41.2 | 22.6 | |
| Per Share | |||||||||||||
| Basic EPS | -20.70 | -10.00 | 18.00 | 13.30 | -11.10 | -1.20 | 20.60 | 5.60 | -9.10 | -7.00 | 15.00 | 8.30 | |
| Diluted EPS | -20.70 | -10.00 | 18.00 | 13.30 | -11.10 | -1.20 | 20.60 | 5.60 | -9.10 | -7.00 | 15.00 | 8.30 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | -1.1 | -0.7 | -0.3 | 1.0 | 0.3 | -0.2 | |
| + Items NOT to be Reclassified to P&L | 0.4 | -0.2 | -0.9 | 0.5 | -0.3 | — | — | -0.7 | -0.3 | 1.0 | 0.3 | -0.2 | |
| + Items to be Reclassified to P&L | — | — | — | — | — | 0.1 | -1.1 | — | — | — | — | — | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | -20.70 | -10.00 | 18.00 | 13.30 | -11.10 | -1.20 | 20.60 | 5.60 | -9.10 | -7.00 | 15.00 | 8.30 | |
| Diluted EPS — Continuing Operations | -20.70 | -10.00 | 18.00 | 13.30 | -11.10 | -1.20 | 20.60 | 5.60 | -9.10 | -7.00 | 15.00 | 8.30 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 272.6 | — | 156.0 | — | 266.6 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 76.4 | 105.4 | 241.8 | 261.6 | 112.4 | 162.3 | 281.8 | 243.7 | 362.7 | 158.9 | 311.5 | 303.8 | |
| Gross Margin % | 27.27 | 35.18 | 31.33 | 26.27 | 28.37 | 37.59 | 30.22 | 28.58 | 28.84 | 33.41 | 32.26 | 27.73 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | -62.6 | -22.3 | 66.8 | 49.1 | -39.4 | -3.7 | 76.3 | 24.5 | -18.2 | -17.0 | 53.5 | 31.7 | |
| − Exceptional Items (reconciliation) | -12.1 | -13.0 | -1.8 | 0.0 | 0.0 | 0.0 | 0.0 | -3.3 | -13.3 | -7.9 | 2.8 | 0.0 | |
| Net Income Adj (tax-effected) | -47.2 | -17.2 | 50.1 | 36.2 | -30.1 | -3.3 | 56.1 | 17.6 | -14.3 | -13.0 | 38.8 | 22.8 | |
| EPS Adj | -17.34 | -6.33 | 18.49 | 13.30 | -11.10 | -1.20 | 20.60 | 6.47 | -5.26 | -4.78 | 14.25 | 8.30 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | |